Business Description
Sagittarius Life Science Corp
NAICS : 325412
SIC : 2834
ISIN : TW0003205001
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 13.57 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.39 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.61 | |||||
Beneish M-Score | -2.12 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.5 | |||||
3-Year EBITDA Growth Rate | 4.2 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | 0.9 | |||||
3-Year Book Growth Rate | -4.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.57 | |||||
9-Day RSI | 36.34 | |||||
14-Day RSI | 40.03 | |||||
6-1 Month Momentum % | -10.16 | |||||
12-1 Month Momentum % | -15.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.92 | |||||
Quick Ratio | 2.54 | |||||
Cash Ratio | 1.9 | |||||
Days Inventory | 30.77 | |||||
Days Sales Outstanding | 31.11 | |||||
Days Payable | 56.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 1.19 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.13 | |||||
Operating Margin % | -14.54 | |||||
Net Margin % | -11.37 | |||||
FCF Margin % | -7.14 | |||||
ROE % | -10.79 | |||||
ROA % | -8.45 | |||||
ROIC % | -21.67 | |||||
ROC (Joel Greenblatt) % | -46.71 | |||||
ROCE % | -10.73 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 126.81 | |||||
PS Ratio | 2.97 | |||||
PB Ratio | 2.66 | |||||
Price-to-Tangible-Book | 2.66 | |||||
EV-to-EBIT | -21.69 | |||||
EV-to-EBITDA | -30.39 | |||||
EV-to-Revenue | 2.56 | |||||
EV-to-FCF | -35.84 | |||||
Price-to-Median-PS-Value | 0.99 | |||||
Price-to-Net-Current-Asset-Value | 7.57 | |||||
Price-to-Net-Cash | 18.88 | |||||
Earnings Yield (Greenblatt) % | -4.61 | |||||
FCF Yield % | -2.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sagittarius Life Science Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 442.93 | ||
EPS (TTM) (NT$) | -1.55 | ||
Beta | 0.17 | ||
Volatility % | 31.77 | ||
14-Day RSI | 40.03 | ||
14-Day ATR (NT$) | 0.775396 | ||
20-Day SMA (NT$) | 41.1325 | ||
12-1 Month Momentum % | -15.66 | ||
52-Week Range (NT$) | 40.05 - 60.9 | ||
Shares Outstanding (Mil) | 32.55 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sagittarius Life Science Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sagittarius Life Science Corp Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Sagittarius Life Science Corp Frequently Asked Questions
What is Sagittarius Life Science Corp(ROCO:3205)'s stock price today?
When is next earnings date of Sagittarius Life Science Corp(ROCO:3205)?
Does Sagittarius Life Science Corp(ROCO:3205) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |